InvestorsHub Logo
Followers 25
Posts 1336
Boards Moderated 0
Alias Born 11/15/2016

Re: Morningwood1 post# 125359

Wednesday, 01/03/2018 10:09:10 PM

Wednesday, January 03, 2018 10:09:10 PM

Post# of 203906
Two products heading into phase 2 trials, both of which they are going to schedule a pre IND meeting with the FDA. Phase 2 trials will take place in Isreal where the research can get done for pennies on the dollar compared to in the US. An Efficacy study being done on Humans, a big step up from the efficacy study done on biological markers that they completed and announced a 70 percent improvement on. Which in the medical world, is considered a possible breakthrough as they stated.

A MM study ongoing which they are scheduled to start a clinical study on in second half of 2018. This study is designed to head to orphan drug.

1 safety study currently in progress on the cream, and another to start in q2 on our tablet.

Leader ship has changed this summer, with definatley a more qualified team in this field.

I will remain long for the above reasons and more!